|
Hi Karenann,
When I post, I feel I am "every woman" because there is so much I do not know, and I know there are plenty more who read here who are like me. So thank you for your patience and understanding with my somewhat simple views.
I find it confusing that the medical system in the U.S.A. has separated out what I see from the posts here to be a reasonably significant group of people who clearly do have HER2 positive bc but who, HERA or no, remain officially irrelevant in regard to any recommendation for treatment with traztuzumab.
If those like me who fall in this group should ignore the silence about this by ASCO and look to HERA for a better answer, what is wrong with the wizards of oncology in the U.S.A. who are responsible for exploring and offering the best possible outcome for those in the U.S.A. like me?
Do you know if off-label drugs that seem appropriate based on HERA results are broadly and routinely paid for by the drug company or medicare for the growing numbers with HER2 bc in the USA who are economically at risk?
AlaskaAngel
|